Bollard Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bollard Group’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,406	Closed	-$9K	–	445
2021 Q3	$9K	Hold	1,406	–	–	﹤0.01%	410
2021 Q2	$12K	Hold	1,406	–	–	﹤0.01%	407
2021 Q1	$13K	Hold	1,406	–	–	﹤0.01%	408
2020 Q4	$16K	Hold	1,406	–	–	﹤0.01%	397
2020 Q3	$15K	Sell	1,406 -4,439	-76%	-$54.4K	﹤0.01%	397
2020 Q2	$77K	Buy	+5,845	New	+$60.6K	﹤0.01%	288

Bollard Group's FLXN Position: Q4 2021 in Review

Bollard Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 1,406 shares — an estimated $9K sold.

Bollard Group first reported a position in FLXN in Q2 2020 and held it in 6 quarters. The position peaked at $77K in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Bollard Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Bollard Group sold 1,406 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $9K.
Bollard Group first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
Bollard Group's Flexion Therapeutics, Inc. position peaked at $77K in Q2 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Bollard Group's 13F filing for Q4 2021, filed 11 Feb 2022.